Canadian R&D spending in 2011 is expected to have totaled CAD 29.9 billion ($29.6 billion), which is 2.0% higher than initial 2010 R&D figures but 1.9% less than in 2008. Business enterprise spending is expected to have grown 5.0% to make up 52% of R&D spending. The sector contributed 47% of R&D funding for a […]
The Korean Health and Welfare Ministry announced that by 2020, the government will spend KRW 146 billion ($126 million) to subsidize drug firms. The funding aims to make Korea the seventh-largest drug industry by increasing its share of the export market from 0.2% to 5.4%. Under the plan, 10 new drugs will be produced by […]
Global growth is slowing, according to the International Monetary Fund’s (IMF) World Economic Outlook, released in September 2011. The IMF expected global economic growth to be 4% through 2012, after 2010 growth of more than 5%, and now plans to lower that prediction. In November 2011, the Organization for Economic Co-operation and Development predicted global […]
Spain’s ministry of science has been eliminated as part of a plan by new People’s Party Prime Minister Mariano Rajoy to cut costs and strengthen the government. The ministry was established in 2000. Four years later, it merged with the ministry of education, until 2008 when Cristina Garmedia was elected science minister. She revised Spain’s […]
Singapore’s 2010 gross expenditures on R&D (GERD) increased 7.4% to SGD 6.5 billion ($5.0 billion) according to a national survey. Business expenditures on R&D (BERD) rose 6.0% to SGD 3.9 billion, for which 799 companies were responsible. The BERD for “electronics, infocomms and media,” the largest market category, grew 0.2% to SGD $2.31 billion. The […]
Isolating the active ingredients from traditional Chinese medicines (TCMs) in order to develop drugs that meet the Western regulatory definition of a drug compound has long proved challenging. Among the problems is the use of traditional techniques for extraction. To improve the development of such drugs, in 2008, China launched the $1.6 billion Innovative New […]
Last month, Egypt announced plans to develop a network of research centers and universities that will complement its upcoming $2 billion science city, which was announced this past May. The Zewail City of Science and Technology network will be connected with research centers that are part of the Ministry of Higher Education and Scientific Research […]
China’s planned foray into the global vaccine market should drive down the vaccine prices of Western drug firms. The World Health Organization (WHO) said in March that China’s drug safety standards are in line with global vaccine regulations, paving the way for Chinese vaccines to be authorized by the WHO and then purchased by United […]
The Food Safety and Standards Authority of India (FSSAI) is finalizing proposals for several standards. A standard for sampling analysis is a major component of the draft, with a panel report expected this month. The draft will then be reviewed by a scientific committee. Other drafts in the works regard import regulation, risk-based analysis, flavors […]
The recent Chinese patent surge is being led by domestic patent applications, those which originated in China. The number of total patent applications filed in China grew 16.7% annually from 2006 to 2010, nearly doubling to 314,000. In 2010, 73% of China’s patent applications were domestic, compared with 52% in 2006. The global share of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.

